Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Yaozhen Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5936-0965; OpenAlex author ID A5102860813. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
7
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. UBE3A-mediated mH2A1 Ubiquitination activates TERT transcription to promote senescence resistance in pancreatic cancer. Last author DOI 10.1038/s41419-026-08480-z↗
  2. PSMD14-Mediated LDHA Deubiquitination Upregulates ACLY Expression via H3K18 Lactylation to Promote Lipid Synthesis and Pancreatic Cancer Progression. Last author DOI 10.1002/advs.202505762↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaobin Fei · 2 shared papers, 2025–2026 · strength 0.53
  2. Rishang Lu · 2 shared papers, 2025–2026 · strength 0.53
  3. Likun Ren · 1 shared paper, 2026 · strength 0.29
  4. Shaojie Chen · 1 shared paper, 2026 · strength 0.29
  5. Peng Liu · 1 shared paper, 2025 · strength 0.24
  6. Xing Wang · 1 shared paper, 2025 · strength 0.24
  7. Yongjia Gao · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.